[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31390]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12822]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Siemens Healthcare Diagnostics, Inc.

    By Notice dated January 26, 2012, and published in the Federal 
Register on February 6, 2012, 77 FR 5847, Siemens Healthcare 
Diagnostics Inc., 100 GBC Drive, Mail Stop 514, Newark, Delaware 19702, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the following basic 
classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Ecgonine (9180)............................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The company plans to produce the listed controlled substances in 
bulk to be used in the manufacture of reagents and drug calibrator 
controls which are DEA exempt products.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Siemens Healthcare Diagnostics Inc., to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc., 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12822 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P